ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FD01 | BioTech | Trastuzumab - 150mg | 10327 | 200219/1 | ARYOTRUST | 150mg | 1 | Injectable powder for concentrate for solution | Infusion | Lebiran SARL | Aryogen Pharmed | Iran | 21,176,745 L.L | 2.44 | E2 | Aryogen Pharmed | Iran | 12/12/20 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FD01 | BioTech | Trastuzumab - 150mg | 10211 | 38120/1 | TRAZIMERA | 150mg | 1 | Injectable powder for solution | Infusion | Droguerie Fattal S.A.L. | Pfizer Manufacturing Belgium NV | Belgium | 28,550,630 L.L | 19.35 | D | pfizer Canada ULC | Canada | 12/12/20 | 0 |
L01FD01 | BioTech | Trastuzumab - 150mg | 10652 | 176919/1 | HERZUMA | 150mg | 1 | Injectable powder for concentrate for solution | Infusion | Droguerie Mercury S.A.L. | Celltrion Inc. | Korea | 36,062,671 L.L | 19.35 | D | Hikma Pharmaceuticals | Jordan | 12/12/20 | 0 |